Form 4 for INSP Inspire Medical Systems, Inc.
Accepted 2024-02-13 00:00:00 ET · period of report 2024-02-09 · accession 0001104659-24-019850 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-13 | 2024-02-09 | INSP | NELSON MARILYN C | Dir | M - OptEx | $0.94 | +4,000 | 25.3K | +19% | +$3,760 |
| D | 2024-02-13 | 2024-02-09 | INSP | NELSON MARILYN C | Dir | M - OptEx | $0.00 | -4,000 | 2,555 | -61% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-09 | M | A | 4,000 | $0.94 | 25,267 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-02-09 | M | D | 4,000 | $0.00 | 2,555 | D | $0.94 · — to 2027-04-01 | 4,000 Common Stock | (F3) The Reporting Person's prior Form 4 incorrectly stated the the number of options remaining following reported transactions on October 17, 2023, which has been corrected herein. (F2) The option is fully vested and exercisable. |